PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL (2002) Nat Med 8: 1145-52 Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells. Van Dross R, Yao S, Asad S, Westlake G, Mays DJ, Barquero L, Duell S, Pietenpol JA, Browning PJ (2005) J Natl Cancer Inst 97: 656-66 Conditional ablation of Ikkb inhibits melanoma tumor development in mice. Yang J, Splittgerber R, Yull FE, Kantrow S, Ayers GD, Karin M, Richmond A (2010) J Clin Invest 120: 2563-74 Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL (2000) Proc Natl Acad Sci U S A 97: 9609-14 Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression. Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B (2007) Cancer Res 67: 3135-44 Down-regulation of p57Kip2 induces prostate cancer in the mouse. Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP, Hayward SW, Wills ML, Logan SK, Zhang P, Matusik RJ (2008) Cancer Res 68: 3601-8 ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. Lenferink AE, Busse D, Flanagan WM, Yakes FM, Arteaga CL (2001) Cancer Res 61: 6583-91 Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Myers JS, Zhao R, Xu X, Ham AJ, Cortez D (2007) Cancer Res 67: 6685-90 Phosphorylation of MdmX by CDK2/Cdc2(p34) is required for nuclear export of Mdm2. Elias B, Laine A, Ronai Z (2005) Oncogene 24: 2574-9 BAD/BCL-[X(L)] heterodimerization leads to bypass of G0/G1 arrest. Chattopadhyay A, Chiang CW, Yang E (2001) Oncogene 20: 4507-18 p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Stewart ZA, Leach SD, Pietenpol JA (1999) Mol Cell Biol 19: 205-15 Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Law BK, Chytil A, Dumont N, Hamilton EG, Waltner-Law ME, Aakre ME, Covington C, Moses HL (2002) Mol Cell Biol 22: 8184-98 Identification of breast cancer peptide epitopes presented by HLA-A*0201. Hawkins OE, Vangundy RS, Eckerd AM, Bardet W, Buchli R, Weidanz JA, Hildebrand WH (2008) J Proteome Res 7: 1445-57 Specific residues within the alpha 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways. Klekotka PA, Santoro SA, Wang H, Zutter MM (2001) J Biol Chem 276: 32353-61 Cell cycle-dependent regulation of a human DNA helicase that localizes in DNA damage foci. Gu J, Xia X, Yan P, Liu H, Podust VN, Reynolds AB, Fanning E (2004) Mol Biol Cell 15: 3320-32 Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. Klekotka PA, Santoro SA, Ho A, Dowdy SF, Zutter MM (2001) Am J Pathol 159: 983-92 Phosphorylation of Rad9 at serine 328 by cyclin A-Cdk2 triggers apoptosis via interfering Bcl-xL. Zhan Z, He K, Zhu D, Jiang D, Huang YH, Li Y, Sun C, Jin YH (2012) PLoS One 7: e44923 Covalent Modification of CDK2 by 4-Hydroxynonenal as a Mechanism of Inhibition of Cell Cycle Progression. Camarillo JM, Rose KL, Galligan JJ, Xu S, Marnett LJ (2016) Chem Res Toxicol 29: 323-32 Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. Ohmori T, Yang JL, Price JO, Arteaga CL (1998) Exp Cell Res 245: 350-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.